BridgeBio Pharma Inc —— 资产负债表 (NASDAQ:BBIO) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 703.59 M1.01 B623.04 M546.38 M919.34 M936.02 M 负债总额 595.7 M1.88 B1.87 B1.89 B2.38 B3.01 B 权益总额 106.26 M-867 M-1.24 B-1.34 B-1.46 B-2.08 B 负债及股东权益总额 703.59 M1.01 B623.04 M546.38 M919.34 M936.02 M 总债务 94.01 M431.05 M430.99 M446.44 M437.34 M2.02 B 净债务 -496.2 M-383.55 M-24.98 M24.67 M-234.56 M1.43 B

新闻

TechnipFMC Defies Market, Hits Record High, Leads 16 Top Performers To IBD Best Stock Lists

Oil Major EQT Pops To Record High, Leads 23 Hot Names New To Best Stock Lists

Tracking Ole Andreas Halvorsen’s Viking Global Portfolio – Q4 2025 Update

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Monday’s insider activity: Vail Resorts CEO buys $4.9 million

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Leerink Partners重申BridgeBio股票跑赢大盘评级,目标价98美元

Leerink Partners reiterates Outperform on BridgeBio stock at $98

BridgeBio Pharma, Inc. (BBIO) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

BridgeBio公布LGMD2I/R9疗法积极中期数据

BridgeBio presents positive interim data for LGMD2I/R9 therapy

JPMorgan adds BridgeBio to focus list, lifts target to $94